Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Cabozantinib After a Previous Immune Checkpoint Inhibitor in Metastatic Renal Cell Carcinoma: A Retrospective Multi-Institutional AnalysisTarget Oncol 2020 Jul 15;[EPub Ahead of Print], R Iacovelli, C Ciccarese, G Facchini, M Milella, F Urbano, U Basso, U De Giorgi, R Sabbatini, D Santini, R Berardi, M Santoni, S Bracarda, F Massari, C Masini, M De Tursi, R Ricotta, S Buti, F Zustovich, P Sepe, S Rossetti, M Maruzzo, E Cortesi, G Tortora, G Procopio
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.